Scientific Papers

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases | Fluids and Barriers of the CNS


  • Andrén K, Wikkelsø C, Hellström P, Tullberg M, Jaraj D. Early shunt surgery improves survival in idiopathic normal pressure hydrocephalus. Eur J Neurol. 2021;28(4):1153–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cabral D, Beach TG, Vedders L, Sue LI, Jacobson S, Myers K, et al. Frequency of Alzheimer’s disease pathology at autopsy in patients with clinical normal pressure hydrocephalus. Alzheimers Dement J Alzheimers Assoc. 2011;7(5):509–13.

    Article 

    Google Scholar
     

  • Miyajima M, Nakajima M, Ogino I, Miyata H, Motoi Y, Arai H. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol. 2013;20(2):236–42.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Craven CL, Baudracco I, Zetterberg H, Lunn MPT, Chapman MD, Lakdawala N, et al. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus. Acta Neurochir. 2017;159(12):2293–300.

    Article 
    PubMed 

    Google Scholar
     

  • Ågren-Wilsson A, Lekman A, Sjöberg W, Rosengren L, Blennow K, Bergenheim AT, et al. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand. 2007;116(5):333–9.

    Article 
    PubMed 

    Google Scholar
     

  • Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, Medeiros R. Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease. J Neuroinflammation. 2018;15(1):276.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sosvorova L, Vcelak J, Mohapl M, Vitku J, Bicikova M, Hampl R. Selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus. Neuro Endocrinol Lett. 2014;35(7):586–93.

    PubMed 

    Google Scholar
     

  • Wang Z, Zhang Y, Hu F, Ding J, Wang X. Pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus. CNS Neurosci Ther. 2020;26(12):1230–40.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005 Sep;57(3 Suppl):S4–16; discussion ii-v.

  • McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456–77.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Boström G, Freyhult E, Virhammar J, Alcolea D, Tumani H, Otto M, et al. Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid. J Alzheimers Dis. 2021;81(2):629–40.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lolansen SD, Rostgaard N, Barbuskaite D, Capion T, Olsen MH, Norager NH, et al. Posthemorrhagic hydrocephalus associates with elevated inflammation and CSF hypersecretion via activation of choroidal transporters. Fluids Barriers CNS. 2022;19(1):62.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lolansen SD, Rostgaard N, Andreassen SN, Simonsen AH, Juhler M, Hasselbalch SG, et al. Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus. Fluids Barriers CNS. 2021;18(1):54.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Weiner S, Junkkari A, Sauer M, Luikku A, Rauramaa T, Kokkola T, Herukka SK, Blennow K, Zetterberg H, Leinonen V, Gobom J. Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2023;20(1):40.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci. 1990;87(13):5134–8.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 1991;266(15):9912–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Brown Z, Strieter RM, Neild GH, Thompson RC, Kunkel SL, Westwick J. IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney Int. 1992;42(1):95–101.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Barna BP, Pettay J, Barnett GH, Zhou P, Iwasaki K, Estes ML. Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor. J Neuroimmunol. 1994;50(1):101–7.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Panee J. Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. Cytokine. 2012;60(1):1–12.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lin J, Kakkar V, Lu X. Impact of MCP -1 in Atherosclerosis. Curr Pharm Des. 2014;20(28):4580–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu X, Huang J, Li J, Mao Q, He J. Effects of Liraglutide Combined with Insulin on Oxidative Stress and Serum MCP-1 and NF-kB Levels in Type 2 Diabetes. J Coll Physicians Surg Pak. 2019;29(3):218–21.

    Article 
    PubMed 

    Google Scholar
     

  • Solár P, Zamani A, Kubíčková L, Dubový P, Joukal M. Choroid plexus and the blood–cerebrospinal fluid barrier in disease. Fluids Barriers CNS. 2020;17(1):35.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • MacAulay N, Keep RF, Zeuthen T. Cerebrospinal fluid production by the choroid plexus: a century of barrier research revisited. Fluids Barriers CNS. 2022;19(1):26.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jeppsson A, Wikkelsö C, Blennow K, Zetterberg H, Constantinescu R, Remes AM, et al. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics. J Neurol Neurosurg Psychiatry. 2019;90(10):1117–23.

    Article 
    PubMed 

    Google Scholar
     

  • Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cereb Blood Flow Metab. 2010;30(4):769–82.

    Article 
    PubMed 

    Google Scholar
     

  • Porcellini E, Ianni M, Carbone I, Franceschi M, Licastro F. Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease. Immun Ageing. 2013;10(1):6.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McGrowder DA, Miller F, Vaz K, Nwokocha C, Wilson-Clarke C, Anderson-Cross M, Brown J, Anderson-Jackson L, Williams L, Latore L, Thompson R, Alexander-Lindo R. Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives. Brain Sci. 2021;11(2):215.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Subileau EA, Rezaie P, Davies HA, Colyer FM, Greenwood J, Male DK, et al. Expression of Chemokines and Their Receptors by Human Brain Endothelium: Implications for Multiple Sclerosis. J Neuropathol Exp Neurol. 2009;68(3):227–40.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Burman J, Zjukovskaja C, Svenningsson A, Freyhult E, Wiberg A, Kultima K. Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis. Brain Commun. 2022;5(1):011.

    Article 

    Google Scholar
     

  • Calvani R, Picca A, Landi G, Marini F, Biancolillo A, Coelho-Junior HJ, et al. A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson’s disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study. GeroScience. 2020;42(5):1323–34.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • von Stebut E, Metz M, Milon G, Knop J, Maurer M. Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell–derived TNFα. Blood. 2003;101(1):210–5.

    Article 

    Google Scholar
     

  • Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 2004;36(10):1882–6.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Estevao C, Bowers CE, Luo D, Sarker M, Hoeh AE, Frudd K, et al. CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium. Brain Behav Immun – Health. 2021;18: 100370.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Meeker RB, Williams K, Killebrew DA, Hudson LC. Cell trafficking through the choroid plexus. Cell Adhes Migr. 2012;6(5):390–6.

    Article 

    Google Scholar
     

  • Daldegan MB, Teixeira MM, Talvani A. Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation. Braz J Med Biol Res. 2005;38(9):1359–65.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest. 1999;103(12):1719–27.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cherry JD, Stein TD, Tripodis Y, Alvarez VE, Huber BR, Au R, et al. CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease. PLoS ONE. 2017;12(9):e0185541.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xing Y fei, Zhang Z li, Shi M hua, Ma Y, Chen Y jing. The level of soluble programmed death-1 in peripheral blood of patients with lung cancer and its clinical implications. Chin J Tuberc Respir Dis. 2012. 35(2):102–6.

  • Nagato T, Ohkuri T, Ohara K, Hirata Y, Kishibe K, Komabayashi Y, et al. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy. Cancer Immunol Immunother. 2017;66(7):877–90.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Qin S, Xu L, Yi M, Yu S, Wu K, Luo S. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. Mol Cancer. 2019;18(1):155.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation. J Exp Med. 2000;192(7):1027–34.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Schlingemann J, Leijon M, Yacoub A, Schlingemann H, Zohari S, Matyi-Tóth A, et al. Novel means of viral antigen identification: Improved detection of avian influenza viruses by proximity ligation. J Virol Methods. 2010;163(1):116–22.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Assarsson E, Lundberg M, Holmquist G, Björkesten J, Bucht Thorsen S, Ekman D, et al. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability. PLoS ONE. 2014;9(4):e95192.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang P, Yang Y, Hong T, Zhu G. Proximity ligation assay: an ultrasensitive method for protein quantification and its applications in pathogen detection. Appl Microbiol Biotechnol. 2021;105(3):923–35.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Golomb J. Alzheimer’s disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry. 2000;68(6):778–81.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sengupta K. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases. Prog Neurobiol. 2022. https://doi.org/10.1016/j.pneurobio.2022.102270.

    Article 
    PubMed 

    Google Scholar
     



  • Source link